Meaning Centered Psychotherapy for Palliative Care Patients (MCP-PC)

Sponsor
Fordham University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT03612050
Collaborator
Calvary Hospital, Bronx, NY (Other)
80
2
24

Study Details

Study Description

Brief Summary

This randomized, controlled trial evaluates the effectiveness of an adaptation of a well-established brief, structured existential psychotherapy (Meaning Centered Psychotherapy) specifically tailored to the needs of palliative care patients (MCP-PC). Terminally ill patients with cancer who have been hospitalized in a palliative care hospital will be randomly assigned to either MCP-PC or enhanced usual care. Patients will complete a very short battery of self-report measures before the 3-session intervention, and again 2 and 4 weeks later to determine whether treatment has bolstered spiritual and psychological well-being and improved quality of life.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Meaning Centered Psychotherapy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trialRandomized controlled trial
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Development of Meaning Centered Psychotherapy for Palliative Care Patients
Anticipated Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Sep 30, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Enhanced Usual Care

facilitate any clinical interventions

Behavioral: Meaning Centered Psychotherapy
Manualized, 3-session existential psychotherapy (30-45 minutes/session) with an optional 4th "booster" session. Content focuses on enhancing patients sense of meaning and purpose in life.

Experimental: Meaning Centered Psychotherapy

raise patients' sense of meaning/purpose

Behavioral: Meaning Centered Psychotherapy
Manualized, 3-session existential psychotherapy (30-45 minutes/session) with an optional 4th "booster" session. Content focuses on enhancing patients sense of meaning and purpose in life.

Outcome Measures

Primary Outcome Measures

  1. Spiritual Well Being [Through study completion (approx 6 weeks)]

    Overall spiritual well-being as measured through the self-report FACIT Spiritual Well Being scale

Secondary Outcome Measures

  1. Hopelessness [Through study completion (approx 6 weeks)]

    Self-report rating scale, the Hopelessness Assessment in Illness scale

  2. Acceptance of Death [Through study completion (approx 6 weeks)]

    Subscale derived from the Life Attitude Profile, a self-report measure of meaning and purpose

  3. Health related Quality of life [Through study completion (approx 6 weeks)]

    Single item rating of overall quality of life derived from the McGill Quality of Life Questionnaire

  4. Desire for hastened death [Through study completion (approx 6 weeks)]

    Abbreviated version of the Schedule of Attitudes towards Hastened Death, a measure of desire for hastened death

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Terminal illness with life expectancy of less than 6 months; hospitalized at a palliative care facility in Bronx NY, English speaking
Exclusion Criteria:
  • Cognitive impairment or severe psychiatric symptoms that preclude informed consent or participation in treatment.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Fordham University
  • Calvary Hospital, Bronx, NY

Investigators

  • Principal Investigator: Barry Rosenfeld, PhD, Fordham University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Fordham University
ClinicalTrials.gov Identifier:
NCT03612050
Other Study ID Numbers:
  • R21 NR017728
First Posted:
Aug 2, 2018
Last Update Posted:
Aug 30, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fordham University

Study Results

No Results Posted as of Aug 30, 2021